Stroke, Acute Clinical Trial
— RAVROfficial title:
Optimizing Hand Rehabilitation Post Stroke Using Interactive Virtual Environments
This study investigates the effects of intensive, high dosage task and impairment based training of the hemiparetic hand, using haptic robots integrated with complex gaming and virtual reality simulations. There is a time-limited period of post-ischemic heightened neuronal plasticity during which intensive training may optimally affect the recovery of motor skills, indicating that the timing of rehabilitation is as important as the dosing. However, recent literature indicates a controversy regarding both the value of intensive, high dosage as well as the optimal timing for therapy in the first two months after stroke. This study is designed to empirically investigate this controversy. It is evident that providing additional, intensive therapy during the acute rehabilitation stay is more complicated to implement and difficult for patients to tolerate, than initiating it in the outpatient setting, immediately after discharge. The robotic/VR system is specifically designed to deliver hand and arm training when motion and strength are limited, using adaptive algorithms to drive individual finger movement, gain adaptation and workspace modification to increase finger and arm range of motion, and haptic and visual feedback from mirrored movements to reinforce motor networks in the lesioned hemisphere.
Status | Recruiting |
Enrollment | 114 |
Est. completion date | October 1, 2024 |
Est. primary completion date | October 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 80 Years |
Eligibility | Inclusion Criteria: - unilateral right or left sided stroke within 7 to 30 days of starting study - sufficient cognitive function to follow instructions - Fugl-Meyer (FM) of = 49/66 - intact cutaneous sensation (e.g. ability to detect <4.17 N stimulation using Semmes- Weinstein nylon filaments Exclusion Criteria: - prior stroke with persistent motor impairment or other disabling neurologic condition - non-independent before stroke - receptive aphasia - hemispatial neglect or severe proprioceptive loss - significant illnesses - severe arthritis that limits arm and hand movements - a score of =1 on the NIHSS limb ataxia item |
Country | Name | City | State |
---|---|---|---|
United States | Kessler Institute for Rehabilitation | Saddle Brook | New Jersey |
United States | Kessler Institute for Rehabilitation | West Orange | New Jersey |
Lead Sponsor | Collaborator |
---|---|
New Jersey Institute of Technology | Kessler Foundation, Northeastern University, Rutgers University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Action Research Arm Test (ARAT) | The ARAT assesses upper extremity activity. It is a 19 item test divided into four subscales: grasp, grip, pinch and movement. Scores range from 0-57 with higher scores indicating better performance. | 4 months post stroke | |
Secondary | Action Research Arm Test | The ARAT assesses upper extremity activity. It is a 19 item test divided into four | 6 months post stroke | |
Secondary | Action Research Arm Test | The ARAT assesses upper extremity activity. It is a 19 item test divided into four | 1 month post treatment | |
Secondary | Action Research Arm Test | The ARAT assesses upper extremity activity. It is a 19 item test divided into four | Immediately post treatment (ideally within 72 hours) | |
Secondary | Action Research Arm Test | The ARAT assesses upper extremity activity. It is a 19 item test divided into four | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Cortical Area Representation of the Finger-Hand Muscles | Single-pulse transcranial magnetic stimulation will be used to assay patterns of corticospinal reorganization. Changes in the ipsilesional hand cortical territory for all subjects will be quantified using motor evoked potentials. The topographic representation of the hand and arm muscles will be mapped. | 4 months post stroke | |
Secondary | Cortical Area Representation of the Finger-Hand Muscles | Single-pulse transcranial magnetic stimulation will be used to assay patterns of corticospinal reorganization. Changes in the ipsilesional hand cortical territory for all subjects will be quantified using motor evoked potentials. The topographic representation of the hand and arm muscles will be mapped. | 6 months post stroke | |
Secondary | Cortical Area Representation of the Finger-Hand Muscles | Single-pulse transcranial magnetic stimulation will be used to assay patterns of corticospinal reorganization. Changes in the ipsilesional hand cortical territory for all subjects will be quantified using motor evoked potentials. The topographic representation of the hand and arm muscles will be mapped. | 1 month post treatment | |
Secondary | Cortical Area Representation of the Finger-Hand Muscles | Single-pulse transcranial magnetic stimulation will be used to assay patterns of corticospinal reorganization. Changes in the ipsilesional hand cortical territory for all subjects will be quantified using motor evoked potentials. The topographic representation of the hand and arm muscles will be mapped. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Cortical Area Representation of the Finger-Hand Muscles | Single-pulse transcranial magnetic stimulation will be used to assay patterns of corticospinal reorganization. Changes in the ipsilesional hand cortical territory for all subjects will be quantified using motor evoked potentials. The topographic representation of the hand and arm muscles will be mapped. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | EEG-Based Measure of Resting State Brain Connectivity | Electroencephalography will be used to evaluate resting-state brain connectivity. | 4 months post stroke | |
Secondary | EEG-Based Measure of Resting State Brain Connectivity | Electroencephalography will be used to evaluate resting-state brain connectivity. | 6 months post stroke | |
Secondary | EEG-Based Measure of Resting State Brain Connectivity | Electroencephalography will be used to evaluate resting-state brain connectivity. | 1 month post treatment | |
Secondary | EEG-Based Measure of Resting State Brain Connectivity | Electroencephalography will be used to evaluate resting-state brain connectivity. | Immediately post treatment (ideally within 72 hours) | |
Secondary | EEG-Based Measure of Resting State Brain Connectivity | Electroencephalography will be used to evaluate resting-state brain connectivity. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | EEG-Based Measure of Task-Based Brain Connectivity | Task-based connectivity will be evaluated. | 4 months post stroke | |
Secondary | EEG-Based Measure of Task-Based Brain Connectivity | Electroencephalography will be used to evaluate task-based brain connectivity. | 6 months post stroke | |
Secondary | EEG-Based Measure of Task-Based Brain Connectivity | Electroencephalography will be used to evaluate task-based brain connectivity. | 1 month post treatment | |
Secondary | EEG-Based Measure of Task-Based Brain Connectivity | Electroencephalography will be used to evaluate task-based brain connectivity. | Immediately post treatment (ideally within 72 hours) | |
Secondary | EEG-Based Measure of Task-Based Brain Connectivity | Electroencephalography will be used to evaluate task-based brain connectivity. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Cerebral Oxygenation in Sensorimotor Cortex | Functional near-infrared spectroscopy will be used to quantify cerebral oxygenation in the sensorimotor cortex during a simple motor task. | 4 months post stroke | |
Secondary | Cerebral Oxygenation in Sensorimotor Cortex | Functional near-infrared spectroscopy will be used to quantify cerebral oxygenation in the sensorimotor cortex during a simple motor task. | 6 months post stroke | |
Secondary | Cerebral Oxygenation in Sensorimotor Cortex | Functional near-infrared spectroscopy will be used to quantify cerebral oxygenation in the sensorimotor cortex during a simple motor task. | 1 month post treatment | |
Secondary | Cerebral Oxygenation in Sensorimotor Cortex | Functional near-infrared spectroscopy will be used to quantify cerebral oxygenation in the sensorimotor cortex during a simple motor task. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Cerebral Oxygenation in Sensorimotor Cortex | Functional near-infrared spectroscopy will be used to quantify cerebral oxygenation in the sensorimotor cortex during a simple motor task. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Blocks and Box Test | A unilateral test of manual dexterity scored as the maximum number of blocks that can be moved from one compartment of the box to another of equal size, within 60 seconds. | 4 months post stroke | |
Secondary | Blocks and Box Test | A unilateral test of manual dexterity scored as the maximum number of blocks that can be moved from one compartment of the box to another of equal size, within 60 seconds. | 6 months post stroke | |
Secondary | Blocks and Box Test | A unilateral test of manual dexterity scored as the maximum number of blocks that can be moved from one compartment of the box to another of equal size, within 60 seconds. | 1 month post treatment | |
Secondary | Blocks and Box Test | A unilateral test of manual dexterity scored as the maximum number of blocks that can be moved from one compartment of the box to another of equal size, within 60 seconds. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Blocks and Box Test | A unilateral test of manual dexterity scored as the maximum number of blocks that can be moved from one compartment of the box to another of equal size, within 60 seconds. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Fugl-Meyer Test of Sensorimotor Function After Stroke (UEFM) | An impairment based measure consisting of 33 movements that tests motor and sensation of the affected arm. Higher scores indicate less impairment and more isolated motions. | 4 months post stroke | |
Secondary | Fugl-Meyer Test of Sensorimotor Function After Stroke (UEFM) | An impairment based measure consisting of 33 movements that tests motor and sensation of the affected arm. Higher scores indicate less impairment and more isolated motions. | 6 months post stroke | |
Secondary | Fugl-Meyer Test of Sensorimotor Function After Stroke (UEFM) | An impairment based measure consisting of 33 movements that tests motor and sensation of the affected arm. Higher scores indicate less impairment and more isolated motions. | 1 month post treatment | |
Secondary | Fugl-Meyer Test of Sensorimotor Function After Stroke (UEFM) | An impairment based measure consisting of 33 movements that tests motor and sensation of the affected arm. Higher scores indicate less impairment and more isolated motions. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Fugl-Meyer Test of Sensorimotor Function After Stroke (UEFM) | An impairment based measure consisting of 33 movements that tests motor and sensation of the affected arm. Higher scores indicate less impairment and more isolated motions. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Wolf Motor Function Test | A 15 item timed test of arm and hand use in patients post stroke. The items begin with simple proximal movements and progress to more complex distal hand movements. | 4 months post stroke | |
Secondary | Wolf Motor Function Test | A 15 item timed test of arm and hand use in patients post stroke. The items begin with simple proximal movements and progress to more complex distal hand movements. | 6 months post stroke | |
Secondary | Wolf Motor Function Test | A 15 item timed test of arm and hand use in patients post stroke. The items begin with simple proximal movements and progress to more complex distal hand movements. | 1 month post treatment | |
Secondary | Wolf Motor Function Test | A 15 item timed test of arm and hand use in patients post stroke. The items begin with simple proximal movements and progress to more complex distal hand movements. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Wolf Motor Function Test | A 15 item timed test of arm and hand use in patients post stroke. The items begin with simple proximal movements and progress to more complex distal hand movements. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Coordination between Hand Transport and Grasp during Reaching | The real-world Reach-Grasp test measures the kinematics of everyday movements involving grasping and manipulating household objects. Kinematics of reaching for an object, lifting it from the support, transporting it to a predefined location and releasing the object will be evaluated. Coordination between hand transport and grasping will be evaluated by analyzing hand preshaping during reach. | 4 months post stroke | |
Secondary | Coordination between Hand Transport and Grasp during Reaching | The real-world Reach-Grasp test measures the kinematics of everyday movements involving grasping and manipulating household objects. Kinematics of reaching for an object, lifting it from the support, transporting it to a predefined location and releasing the object will be evaluated. Coordination between hand transport and grasping will be evaluated by analyzing hand preshaping during reach. | 6 months post stroke | |
Secondary | Coordination between Hand Transport and Grasp during Reaching | The real-world Reach-Grasp test measures the kinematics of everyday movements involving grasping and manipulating household objects. Kinematics of reaching for an object, lifting it from the support, transporting it to a predefined location and releasing the object will be evaluated. Coordination between hand transport and grasping will be evaluated by analyzing hand preshaping during reach. | 1 month post treatment | |
Secondary | Coordination between Hand Transport and Grasp during Reaching | The real-world Reach-Grasp test measures the kinematics of everyday movements involving grasping and manipulating household objects. Kinematics of reaching for an object, lifting it from the support, transporting it to a predefined location and releasing the object will be evaluated. Coordination between hand transport and grasping will be evaluated by analyzing hand preshaping during reach. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Coordination between Hand Transport and Grasp during Reaching | The real-world Reach-Grasp test measures the kinematics of everyday movements involving grasping and manipulating household objects. Kinematics of reaching for an object, lifting it from the support, transporting it to a predefined location and releasing the object will be evaluated. Coordination between hand transport and grasping will be evaluated by analyzing hand preshaping during reach. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Arm Range of Motion | Active range of motion for fingers, wrist, elbow and shoulder. | 4 months post stroke | |
Secondary | Arm Range of Motion | Active range of motion for fingers, wrist, elbow and shoulder. | 6 months post stroke | |
Secondary | Arm Range of Motion | Active range of motion for fingers, wrist, elbow and shoulder. | 1 month post treatment | |
Secondary | Arm Range of Motion | Active range of motion for fingers, wrist, elbow and shoulder. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Arm Range of Motion | Active range of motion for fingers, wrist, elbow and shoulder. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Fingertip Pinch Force | Ability to regulate force will be evaluated by measuring the accuracy of tracking square and sine waves presented on a computer screen. Vertical position of the cursor on the screen will be defined by isometric force between the thumb and index fingertips measured by a force sensor. | 4 months post stroke | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Fingertip Pinch Force | Ability to regulate force will be evaluated by measuring the accuracy of tracking square and sine waves presented on a computer screen. Vertical position of the cursor on the screen will be defined by isometric force between the thumb and index fingertips measured by a force sensor. | 6 months post stroke | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Fingertip Pinch Force | Ability to regulate force will be evaluated by measuring the accuracy of tracking square and sine waves presented on a computer screen. Vertical position of the cursor on the screen will be defined by isometric force between the thumb and index fingertips measured by a force sensor. | 1 month post treatment | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Fingertip Pinch Force | Ability to regulate force will be evaluated by measuring the accuracy of tracking square and sine waves presented on a computer screen. Vertical position of the cursor on the screen will be defined by isometric force between the thumb and index fingertips measured by a force sensor. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Fingertip Pinch Force | Ability to regulate force will be evaluated by measuring the accuracy of tracking square and sine waves presented on a computer screen. Vertical position of the cursor on the screen will be defined by isometric force between the thumb and index fingertips measured by a force sensor. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Maximum Thumb and Index Fingertip Pinch Force | A force sensor will be used to measure in Newtons maximum isometric pinch force achieved between the thumb and index fingertips. | 4 months post stroke | |
Secondary | Maximum Thumb and Index Fingertip Pinch Force | A force sensor will be used to measure in Newtons maximum isometric pinch force achieved between the thumb and index fingertips. | 6 months post stroke | |
Secondary | Maximum Thumb and Index Fingertip Pinch Force | A force sensor will be used to measure in Newtons maximum isometric pinch force achieved between the thumb and index fingertips. | 1 month post treatment | |
Secondary | Maximum Thumb and Index Fingertip Pinch Force | A force sensor will be used to measure in Newtons maximum isometric pinch force achieved between the thumb and index fingertips. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Maximum Thumb and Index Fingertip Pinch Force | A force sensor will be used to measure in Newtons maximum isometric pinch force achieved between the thumb and index fingertips. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Isotonic Finger Flexion/Extension | A data glove will be used to evaluate the accuracy of tracking square and sine waves presented on a computer screen with isotonic finger flexion/extension. Vertical position of the cursor on the screen will be defined by the average of four metacarpophalangeal finger joints. | 4 months post stroke | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Isotonic Finger Flexion/Extension | A data glove will be used to evaluate the accuracy of tracking square and sine waves presented on a computer screen with isotonic finger flexion/extension. Vertical position of the cursor on the screen will be defined by the average of four metacarpophalangeal finger joints. | 6 months post stroke | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Isotonic Finger Flexion/Extension | A data glove will be used to evaluate the accuracy of tracking square and sine waves presented on a computer screen with isotonic finger flexion/extension. Vertical position of the cursor on the screen will be defined by the average of four metacarpophalangeal finger joints. | 1 month post treatment | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Isotonic Finger Flexion/Extension | A data glove will be used to evaluate the accuracy of tracking square and sine waves presented on a computer screen with isotonic finger flexion/extension. Vertical position of the cursor on the screen will be defined by the average of four metacarpophalangeal finger joints. | Immediately post treatment (ideally within 72 hours) | |
Secondary | Accuracy of Tracking a Square and Sine Wave with Isotonic Finger Flexion/Extension | A data glove will be used to evaluate the accuracy of tracking square and sine waves presented on a computer screen with isotonic finger flexion/extension. Vertical position of the cursor on the screen will be defined by the average of four metacarpophalangeal finger joints. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Measurement of Daily Use of Upper Extremity | Wearable sensors will be used to quantify daily use of the affected arm after the intervention. | 4 months post stroke | |
Secondary | Measurement of Daily Use of Upper Extremity | Wearable sensors will be used to quantify daily use of the affected arm after the intervention. | 6 months post stroke | |
Secondary | Measurement of Daily Use of Upper Extremity | Wearable sensors will be used to quantify daily use of the affected arm after the intervention. | 1 month post treatment | |
Secondary | EuroQol | The EuroQol - EQ-5D is a standardized instrument used as a measure of health-related quality of life. The descriptive system comprises five dimensions: 1. mobility, the person's walking ability; 2. self-care, the ability to wash or dress by oneself; 3. usual activities dimension, performance in "work, study, housework, family or leisure activities"; 4. pain/discomfort, how much pain or discomfort they have, and 5. anxiety/depression, how much anxious or depressed they are. The respondents self-rate their level of severity for each dimension. | 4 months post stroke | |
Secondary | EuroQol | The EuroQol - EQ-5D is a standardized instrument used as a measure of health-related quality of life. The descriptive system comprises five dimensions: 1. mobility, the person's walking ability; 2. self-care, the ability to wash or dress by oneself; 3. usual activities dimension, performance in "work, study, housework, family or leisure activities"; 4. pain/discomfort, how much pain or discomfort they have, and 5. anxiety/depression, how much anxious or depressed they are. The respondents self-rate their level of severity for each dimension. | 6 months post stroke | |
Secondary | EuroQol | The EuroQol - EQ-5D is a standardized instrument used as a measure of health-related quality of life. The descriptive system comprises five dimensions: 1. mobility, the person's walking ability; 2. self-care, the ability to wash or dress by oneself; 3. usual activities dimension, performance in "work, study, housework, family or leisure activities"; 4. pain/discomfort, how much pain or discomfort they have, and 5. anxiety/depression, how much anxious or depressed they are. The respondents self-rate their level of severity for each dimension. | 1 month post treatment | |
Secondary | EuroQol | The EuroQol - EQ-5D is a standardized instrument used as a measure of health-related quality of life. The descriptive system comprises five dimensions: 1. mobility, the person's walking ability; 2. self-care, the ability to wash or dress by oneself; 3. usual activities dimension, performance in "work, study, housework, family or leisure activities"; 4. pain/discomfort, how much pain or discomfort they have, and 5. anxiety/depression, how much anxious or depressed they are. The respondents self-rate their level of severity for each dimension. | Immediately post treatment (ideally within 72 hours) | |
Secondary | EuroQol | The EuroQol - EQ-5D is a standardized instrument used as a measure of health-related quality of life. The descriptive system comprises five dimensions: 1. mobility, the person's walking ability; 2. self-care, the ability to wash or dress by oneself; 3. usual activities dimension, performance in "work, study, housework, family or leisure activities"; 4. pain/discomfort, how much pain or discomfort they have, and 5. anxiety/depression, how much anxious or depressed they are. The respondents self-rate their level of severity for each dimension. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | National Institutes of Health Stroke Scale (NIHSS) | The NIHSS is a 15-item neurologic examination stroke scale used to evaluate and document neurological status in stroke patients and the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. Ratings for each item are scored with 3 to 5 grades with 0 as normal. | 4 months post stroke | |
Secondary | National Institutes of Health Stroke Scale (NIHSS) | The NIHSS is a 15-item neurologic examination stroke scale used to evaluate and document neurological status in stroke patients and the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. Ratings for each item are scored with 3 to 5 grades with 0 as normal. | 6 months post stroke | |
Secondary | National Institutes of Health Stroke Scale (NIHSS) | The NIHSS is a 15-item neurologic examination stroke scale used to evaluate and document neurological status in stroke patients and the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. Ratings for each item are scored with 3 to 5 grades with 0 as normal. | 1 month post treatment | |
Secondary | National Institutes of Health Stroke Scale (NIHSS) | The NIHSS is a 15-item neurologic examination stroke scale used to evaluate and document neurological status in stroke patients and the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. Ratings for each item are scored with 3 to 5 grades with 0 as normal. | Immediately post treatment (ideally within 72 hours) | |
Secondary | National Institutes of Health Stroke Scale (NIHSS) | The NIHSS is a 15-item neurologic examination stroke scale used to evaluate and document neurological status in stroke patients and the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. Ratings for each item are scored with 3 to 5 grades with 0 as normal. | Immediately prior to treatment (ideally within 72 hours) | |
Secondary | Change in Robot-Based Measure of Elbow-Shoulder Coordination during Reaching | To compare the immediate effects of training in the EVR and DVR groups, subjects will reach to five haptically rendered spheres located in a 3D virtual environment. The test will be performed every day immediately prior to VR training to measure changes in patterns of elbow-shoulder coordination. | Day 1 and and Day 10 of treatment for EVR and DVR groups | |
Secondary | Change in Robot-Based Measure of Maximum Seated Workspace during Reaching | To compare the immediate effects of training in the EVR and DVR groups, subjects will reach to five haptically rendered spheres located in a 3D virtual environment. The test will be performed every day immediately prior to VR training to measure changes in maximum seated workspace. | Day 1 and and Day 10 of treatment for EVR and DVR groups | |
Secondary | Change in Robot-Based Measure of Movement Speed during Arm Reaching | To compare the immediate effects of training in the EVR and DVR groups, subjects will reach to five haptically rendered spheres located in a 3D virtual environment. The test will be performed immediately prior to VR training to measure changes in arm speed during reaching for a virtual target. | Day 1 and and Day 10 of treatment for EVR and DVR groups | |
Secondary | Change in Robot-Based Measure of Movement Speed during Targeted Finger Motion | To compare the immediate effects of training in the EVR and DVR groups, subjects will perform targeted finger movements in a virtual environment. The test will be performed every day immediately prior to VR training to measure changes in the speed of finger movement towards a virtual target. | Day 1 and and Day 10 of treatment for EVR and DVR groups | |
Secondary | Patient's Structured Subjective Assessment | This is a 27 item questionnaire that addresses the subjects perception of the function of their hemiplegic arm and the effect this intervention had on their hand function. Subjects fill out the questionnaire prior to and directly after the intervention. Some questions require a response such as disagree, neutral and agree, others require ordering their gaming activity preferences, or responding to a question with a short answer. | Immediately post treatment (ideally within 72 hours) for EVR and DVR groups |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Completed |
NCT03679637 -
Tablet-based Aphasia Therapy in the Acute Phase After Stroke
|
N/A | |
Completed |
NCT03574038 -
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
|
N/A | |
Completed |
NCT03633422 -
Evaluation of Stroke Patient Screening
|
||
Completed |
NCT04088578 -
VNS-supplemented Motor Retraining After Stroke
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Not yet recruiting |
NCT05534360 -
Tenecteplase Treatment in Ischemic Stroke Registry
|
||
Withdrawn |
NCT05786170 -
ERILs Und SNILs Unter SOC
|
N/A | |
Not yet recruiting |
NCT04105322 -
Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients
|
N/A | |
Recruiting |
NCT03132558 -
Contrast Induced Acute Kidney in Patients With Acute Stroke
|
N/A | |
Completed |
NCT02893631 -
Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
|
||
Active, not recruiting |
NCT02274727 -
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
|
||
Completed |
NCT02225730 -
Imaging Collaterals in Acute Stroke (iCAS)
|
||
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Active, not recruiting |
NCT01581502 -
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00761982 -
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
|
Phase 1/Phase 2 | |
Completed |
NCT00535197 -
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
|
Phase 1/Phase 2 | |
Terminated |
NCT00132509 -
FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT05760326 -
Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients
|